Carcinoma, Ductal, Breast - 25 Studies Found
Recruiting |
: Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer : Ductal Breast Carcinoma In Situ : 2015-12-18 :
|
Recruiting |
: MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ : Ductal Breast Carcinoma In Situ : 2015-01-16 :
|
Recruiting |
: G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer :
|
Terminated |
: A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS) : Breast Carcinoma : 2005-09-12 :
|
Completed |
: Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ : Breast Cancer : 2010-05-26 :
|
Not yet recruiting |
: Tamoxifen Citrate or Afimoxifene in Treating Patients With Estrogen Receptor Positive Breast Cancer :
: 2016-12-14 : |
Recruiting |
: Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection :
|
Recruiting |
: Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers : Breast Cancer : 2008-12-05 : Procedure: contrast-enhanced magnetic resonance imaging |
Recruiting |
: Conjugated Estrogens/Bazedoxifene in Treating Patients With Ductal Carcinoma in Situ Undergoing Surgery :
: 2016-02-24 :
|
Active, not recruiting |
: Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy :
: 2008-10-08 :
|